CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in DNLI — Denali Therapeutics Inc.
CIK 884546
SAN FRANCISCO, CA
Position in DNLI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,182,060
+$3,362,218 QoQ
Shares Held
1,207,399
+0.6% QoQ
Ownership
0.761%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99610733485783.ToString("F0")%
Shared 0.ToString("F0")%
None 0.0038926651421775237.ToString("F0")%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,181,979,796 across 287 Biotechnology names. DNLI ranks #55 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in DNLI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,182,060 | 1,207,399 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,819,842 | 1,200,475 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,718,095 | 1,151,384 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $14,773,705 | 1,056,019 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,729,536 | 1,009,896 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $20,960,055 | 1,028,462 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $29,590,545 | 1,015,810 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $24,597,038 | 1,059,304 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $21,362,530 | 1,041,059 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $21,610,155 | 1,006,997 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $20,239,247 | 981,059 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $25,603,790 | 867,631 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $19,268,997 | 836,328 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,267,876 | 836,673 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $22,430,707 | 730,880 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,528,692 | 731,522 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,655,754 | 704,251 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $31,986,674 | 717,190 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $35,504,288 | 703,752 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $50,219,954 | 640,234 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $32,290,963 | 565,516 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $41,310,264 | 493,198 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $17,429,145 | 486,440 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,394,728 | 471,246 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $7,330,946 | 418,672 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||